Guideline for the Prescribing of Novel Oral Anticoagulants (NOACs): Dabigatran (Pradaxa ), Rivaroxaban (Xarelto ), Apixaban (Eliquis ) - PDF Free Download
Anticoagulation Strategies in Patients With Cancer: JACC Review Topic of the Week - ScienceDirect
Guidance on converting between anticoagulants
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges | Journal of the American Heart Association
Oral anticoagulants in the management of venous thromboembolism | Nature Reviews Cardiology
Time for a change? Switching anticoagulants in patients with AF or VTE | Thrombosis Adviser
Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons | The BMJ
Dose of XARELTO for Switching From Another Anticoagulant During Initial DVT or PE Treatment
Cureus | Clinical Outcomes and Costs of Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Inpatients: A Cross-Sectional Study
Xarelto® - Responsible Use
RBCP - Cost comparison between enoxaparin and new oral anticoagulants dabigatran and rivaroxaban in venous thromboembolism prophylaxis
New Oral Anticoagulants: A Review - ppt video online download
Treatment Considerations | XARELTO® (rivaroxaban) HCP
Safety Profile - DVT & PE Initial Treatment | XARELTO® (rivaroxaban) HCP
Updated Guidelines on Outpatient Anticoagulation | AAFP
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges | Journal of the American Heart Association
Direct Oral Anticoagulants: A User's Guide | Consultant360
Recommendations for Switching to and From Rivaroxaban 9 | Download Table
Transition of Anticoagulants 2016
Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology | Revista Española de Cardiología
Apixaban starting dose after 1 week LMWH therapy (PE or DVT)? | ResearchGate
Cureus | Current Trends in the Duration of Anticoagulant Therapy for Venous Thromboembolism: A Systematic Review
Rivaroxaban: a fully-subsidised oral anticoagulant
Care Transitions in Anticoagulation Management for Patients With Atrial Fibrillation: An Emphasis on Safety | Ochsner Journal
